Physician profile
John J Yu
NPI 1821258880
$4,095.60
in general payments reported to CMS, 2019-2025
16 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $74.32 · 2021: $106 · 2022: $363 · 2023: $58.86 · 2024: $2,551 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,703 · Travel and Lodging: $1,506 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,702.72 |
| Travel and Lodging | $1,506.04 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,388.36 | 2024-2025 | |
| Polaris Technology Solutions LLC | $861.52 | 2024 | |
| Djo, LLC | $489.27 | 2019-2025 | Cmf |
| Stryker Corporation | $259.28 | 2022-2025 | Invision, Infinity Adaptis |
| Zimmer Biomet Holdings, INC. | $239.03 | 2025 | Mymobility Platform, G7 |
| Smith+Nephew, INC. | $233.80 | 2019-2022 | |
| Linvatec Corporation | $174.99 | 2024 | Biobrace 23mm |
| Treace Medical Concepts, INC. | $112.97 | 2024-2025 | |
| Bioventus LLC | $106.45 | 2021 | |
| Wright Medical Technology, INC. | $74.62 | 2019-2020 | |
| Nuvasive, INC. | $51.94 | 2020 | |
| Kerecis Limited | $38.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Gramercy Extremity Orthopedics LLC | $20.38 | 2024 | |
| Paragon 28, INC. | $20.30 | 2023 | Jaws |
| Overture Orthopaedics | $18.53 | 2025 | Overtureti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $5.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,285.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.